Category | Term | Count | Count % | P-Value |
KEGG_PATHWAY | Neuroactive ligand-receptor interaction | 18 | 27.7 | 7.1E−11 |
KEGG_PATHWAY | Pathways in cancer | 18 | 27.7 | 1.6E−08 |
KEGG_PATHWAY | Calcium signaling pathway | 13 | 20 | 2.6E−08 |
KEGG_PATHWAY | Hepatitis B | 11 | 16.9 | 3.3E−07 |
KEGG_PATHWAY | Cholinergic synapse | 10 | 15.4 | 3.4E−07 |
KEGG_PATHWAY | Colorectal cancer | 8 | 12.3 | 8.1E−07 |
KEGG_PATHWAY | Morphine addiction | 9 | 13.8 | 8.8E−07 |
KEGG_PATHWAY | Thyroid hormone signaling pathway | 9 | 13.8 | 0.0000052 |
KEGG_PATHWAY | Estrogen signaling pathway | 8 | 12.3 | 0.000019 |
KEGG_PATHWAY | Retrograde endocannabinoid signaling | 8 | 12.3 | 0.000022 |
KEGG_PATHWAY | Serotonergic synapse | 8 | 12.3 | 0.00004 |
KEGG_PATHWAY | Small cell lung cancer | 7 | 10.8 | 0.000079 |
KEGG_PATHWAY | Progesterone-mediated oocyte maturation | 7 | 10.8 | 0.000091 |
KEGG_PATHWAY | Prostate cancer | 7 | 10.8 | 0.000097 |
KEGG_PATHWAY | PI3K-Akt signaling pathway | 12 | 18.5 | 0.00014 |
KEGG_PATHWAY | Adrenergic signaling in cardiomyocytes | 8 | 12.3 | 0.00016 |
KEGG_PATHWAY | VEGF signaling pathway | 6 | 9.2 | 0.00016 |
KEGG_PATHWAY | Apoptosis | 6 | 9.2 | 0.00017 |
KEGG_PATHWAY | Amphetamine addiction | 6 | 9.2 | 0.00023 |
KEGG_PATHWAY | p53 signaling pathway | 6 | 9.2 | 0.00025 |
KEGG_PATHWAY | Non-alcoholic fatty liver disease (NAFLD) | 8 | 12.3 | 0.00028 |
KEGG_PATHWAY | Viral carcinogenesis | 9 | 13.8 | 0.00033 |
KEGG_PATHWAY | Toxoplasmosis | 7 | 10.8 | 0.00033 |
KEGG_PATHWAY | Nicotine addiction | 5 | 7.7 | 0.00035 |
KEGG_PATHWAY | Tuberculosis | 8 | 12.3 | 0.00073 |
KEGG_PATHWAY | GABAergic synapse | 6 | 9.2 | 0.00076 |
KEGG_PATHWAY | Salivary secretion | 6 | 9.2 | 0.0008 |
KEGG_PATHWAY | Amyotrophic lateral sclerosis (ALS) | 5 | 7.7 | 0.00084 |